ABCG2 and Thrombocytopenia: There was no heterogeneity between studies assessing the relationships of the ABCG2 rs2231142 polymorphism with sunitinib-induced thrombocytopenia (I2 = 0, p > 0.05), and the fixed-effects model was applied to the analysis.